Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 23, 2023: Darovasertib (oral) and Crizotinib (oral) / Uveal Melanoma / Ideaya: Positive Phase 2 data and successful FDA Type C meeting on registrational trial design Ideaya […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id